Skip to content
Vibe Bio logo in black.
  • Why AI analytics?
  • Product
  • Venture fund
  • Resources
    • Blog
    • Events
    • Library
    • Media
  • About us
    • FAQ
    • Our Team
  • Contact Us
  • Why AI analytics?
  • Product
  • Venture fund
  • Resources
    • Blog
    • Events
    • Library
    • Media
  • About us
    • FAQ
    • Our Team
  • Contact Us
Contact us

Tag: AI

Revolutionizing Drug Development for Rare Diseases Through AI | Alok Tayi

Revolutionizing Drug Development for Rare Diseases through AI

“In this episode, Alok shares his personal story of how medical conditions in his family led to the creation of Vibe Bio, and how the company aims to identify diseases with unmet needs, leveraging AI to find medicines with the highest chances of providing cures.”

Mother-Son Duo Offer Biopharma KOL Mapping with Adnexi CEO Sandra Shpilberg

Biopharma KOL Mapping

Sandra Shpilberg, Co-founder and CEO of Adnexi, discusses using AI to develop effective strategies for biopharma key expert and digital opinion leader selection to elevate your product launch.

The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio

The Biotech Startups Podcast with guest Alok Tayi, Founder & CEO of Vibe Bio

Learn how Vibe Bio is tackling the problem of funding & guiding high potential drug programs.

STAT – Upending drug industry financing

STAT – Upending drug industry financing

This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing.

← Previous
Vibe Bio Logo in white.
Linkedin

©2025 Vibe Bio. All rights reserved.

Platform

Why AI analytics?

VibeOne product

Investment

Venture fund

Portfolio

Investment partners

Resources

Blog

Terms and conditions

Privacy policy

Company

About us

Our team

Media

Careers

FAQ